Cargando…

Omalizumab therapy in a 13-year-old boy with severe persistent asthma and concomitant eosinophilic esophagitis

BACKGROUND: Eosinophilic esophagitis (EoE) has been defined as “asthma of the esophagus” for the large number of similarities between the two diseases. Omalizumab is an anti-Immunoglobulin E (IgE) antibody currently approved only in allergic IgE-mediated severe persistent uncontrolled asthma and in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arasi, Stefania, Costa, Stefano, Magazzù, Giuseppe, Ieni, Antonio, Crisafulli, Giuseppe, Caminiti, Lucia, Chiera, Fernanda, Vaccaro, Mario, Del Giudice, Michele Miraglia, Pajno, Giovanni Battista
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4802852/ https://www.ncbi.nlm.nih.gov/pubmed/27000314 http://dx.doi.org/10.1186/s13052-016-0243-x

Ejemplares similares

Omalizumab in children with severe allergic disease: a case series
por: Crisafulli, Giuseppe, et al.
Publicado: (2019)

Allergen immunotherapy
por: Crisafulli, Giuseppe, et al.
Publicado: (2014)

Long term treatment with omalizumab in adolescent with refractory solar urticaria
por: Iannelli, Mauro, et al.
Publicado: (2021)

Oral immunotherapy in clinical practice
por: Arasi, Stefania, et al.
Publicado: (2015)

The safety of oral immunotherapy for food allergy during maintenance phase: Effect of counselling on adverse reactions
por: Arasi, Stefania, et al.
Publicado: (2019)

Food protein induced enterocolitis syndrome caused by rice beverage
por: Caminiti, Lucia, et al.
Publicado: (2013)

A Pilot Study of Omalizumab in Eosinophilic Esophagitis
por: Loizou, Denise, et al.
Publicado: (2015)

Long-Term Safety of Omalizumab in Children with Asthma and/or Chronic Spontaneous Urticaria: A 4-Year Prospective Study in Real Life
por: Galletta, Francesca, et al.
Publicado: (2023)

Successful management of severe asthma in a young boy with eosinophilic chronic rhinosinusitis who received omalizumab: a case report
por: Shoda, Yasuho, et al.
Publicado: (2019)

Pediatric eosinophilic esophagitis: a review for the clinician
por: Barni, Simona, et al.
Publicado: (2021)

Concomitant Segmental Vitiligo and Segmental Morphea in an 8-year-old boy
por: Magri, Francesca, et al.
Publicado: (2021)

The clinical benefit of mepolizumab replacing omalizumab in uncontrolled severe eosinophilic asthma
por: Chapman, Kenneth R., et al.
Publicado: (2019)

Esophageal polyp in a teenage boy with eosinophilic esophagitis
por: Schor, Berni, et al.
Publicado: (2022)

Treatment response with mepolizumab in severe eosinophilic asthma patients with previous omalizumab treatment
por: Magnan, A., et al.
Publicado: (2016)

Update: Mepolizumab treatment in patients with severe eosinophilic asthma and prior omalizumab use
por: Albers, Frank C., et al.
Publicado: (2019)

Omalizumab Restores Response to Corticosteroids in Patients with Eosinophilic Chronic Rhinosinusitis and Severe Asthma
por: Kobayashi, Yoshiki, et al.
Publicado: (2021)

Effectiveness of benralizumab for allergic and eosinophilic predominant asthma following negative initial results with omalizumab
por: Minami, Daisuke, et al.
Publicado: (2018)

Clinical and economic consequences of switching from omalizumab to mepolizumab in uncontrolled severe eosinophilic asthma
por: Carpagnano, Giovanna Elisiana, et al.
Publicado: (2021)

Benefit of switching to mepolizumab from omalizumab in severe eosinophilic asthma based on patient characteristics
por: Liu, Mark C., et al.
Publicado: (2021)

Comparison of omalizumab and mepolizumab treatment efficacy in patients with atopic and eosinophilic “Overlap” severe asthma: Biological agent preference in atopic-eosinophilic severe asthma
por: Tepetam, Fatma Merve, et al.
Publicado: (2023)

Esophageal Intramural Pseudodiverticulosis and Concomitant Eosinophilic Esophagitis: A Case Series
por: Scaffidi, Michael A., et al.
Publicado: (2016)

Omalizumab effectiveness in patients with severe allergic asthma according to blood eosinophil count: the STELLAIR study
por: Humbert, Marc, et al.
Publicado: (2018)

Switch from Omalizumab to Benralizumab in Allergic Patients with Severe Eosinophilic Asthma: A Real-Life Experience from Southern Italy
por: Pelaia, Corrado, et al.
Publicado: (2021)

Severe asthma and the omalizumab option
por: Miller, Christopher WT, et al.
Publicado: (2008)

Omalizumab treatment in brittle asthma
por: Skiepko, Roman, et al.
Publicado: (2014)

Omalizumab for Severe Asthma: Beyond Allergic Asthma
por: Loureiro, C. C., et al.
Publicado: (2018)

The future outlook on allergen immunotherapy in children: 2018 and beyond
por: Arasi, Stefania, et al.
Publicado: (2018)

4-month omalizumab efficacy outcomes for severe allergic asthma: the Dutch National Omalizumab in Asthma Registry
por: Snelder, S. M., et al.
Publicado: (2017)

P23 - Boy with severe atopic dermatitis treated with omalizumab
por: Stefanaki, Evangelia, et al.
Publicado: (2014)

A patient case demonstrating the efficacy of benralizumab in uncontrolled severe eosinophilic asthma refractory to omalizumab and mepolizumab treatment
por: Davison, John, et al.
Publicado: (2021)

Omalizumab: Clinical Use for the Management of Asthma
por: Thomson, Neil C., et al.
Publicado: (2012)

A case of relapsing chronic eosinophilic pneumonia treated by Omalizumab
por: Nehme, Ralph, et al.
Publicado: (2022)

Omalizumab as add-on therapy in patients with asthma and allergic bronchopulmonary aspergillosis
por: da Cunha, Fernanda Sales, et al.
Publicado: (2018)

A Case of Severe Asthma with Eosinophilic Otitis Media Successfully Treated with Anti-IgE Monoclonal Antibody Omalizumab
por: Okude, Azusa, et al.
Publicado: (2012)

Improvement of quality of life in patients with concomitant allergic asthma and atopic dermatitis: one year follow-up of omalizumab therapy
por: Velling, P, et al.
Publicado: (2011)

The Clinical Characteristics and Treatment Outcomes of Concomitant Eosinophilic Esophagitis and Inflammatory Bowel Disease
por: Urquhart, Siri A, et al.
Publicado: (2021)

Update on optimal use of omalizumab in management of asthma
por: Pelaia, Girolamo, et al.
Publicado: (2011)

279 Near-Fatal Asthma Treated with Omalizumab
por: Contreras Contreras, Elvia Angelica, et al.
Publicado: (2012)

A review of omalizumab for the management of severe asthma
por: Lin, Ching-Hsiung, et al.
Publicado: (2016)

Effective omalizumab treatment influenced eosinophil function in severe allergic asthmatics
por: Yan, Huacheng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_i5gt7uhlcc79vc355cb0uqilmf